Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anesthetic esketamine vs dexmedetomidine on recovery after cesarean section under spinal anesthesia
ChiCTR2600127445Phase 4Recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and dexmedetomidine in postoperative pain, sleep disorder, anxiety disorder and 1 more (3 arms), sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoint: Obstetric Quality of Recovery (ObsQoR-10). Started Jul 2026; status: recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
postoperative painsleep disorderanxiety disorderpostpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2600127445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127445.